SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...
The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...
AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback